Home
Conditions
Gallbladder Cancer

Clinical trial condition

Gallbladder Cancer

Explore clinical trials studying Gallbladder Cancer. Study availability and eligibility vary by location and protocol.

81 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Gallbladder Cancer trial results

Completed

Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction

NCT00280709

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +16 more
Locations: Department of Surgery, University Hospital Linköping, Sweden

View Trial Details

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions: Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations: Arizona Cancer Center Tuscon, Arizona, United States

Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States

H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States

Nevada Cancer Institute Sparks, Nevada, United States

View Trial Details

Completed

Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer

NCT00409864

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +14 more
Locations: All India Institute of Medical Sciences, New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Quality Of Life in Patients With Malignant Biliary Obstruction

NCT00579865

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +12 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Avastin and Tarceva for Upper Gastrointestinal Cancers

NCT00350753

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: Århus Sygehus Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Completed

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

NCT00123825

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

NCT02293954

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Predicting Incidental Gallbladder Cancer

NCT06531408

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
Locations: University Hospitals Plymouth NHS Trust Plymouth, Devon, United Kingdom

View Trial Details

Active, Not Recruiting

Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

NCT04308174

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

NCT06717464

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +14 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Gallbladder Cancer

Gallbladder Cancer trial results

Related conditions